These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22276018)

  • 1. Role of traditional and new biomarkers in breast carcinogenesis.
    Macis D; Cazzaniga M; De Censi A; Bonanni B
    Ecancermedicalscience; 2009; 3():157. PubMed ID: 22276018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker Studies in Early Detection and Prognosis of Breast Cancer.
    Li G; Hu J; Hu G
    Adv Exp Med Biol; 2017; 1026():27-39. PubMed ID: 29282678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
    Kashyap D; Kaur H
    Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of breast cancer chemopreventive drugs.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Doody LA; Greenwald P
    J Cell Biochem Suppl; 1993; 17G():2-13. PubMed ID: 8007699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for risk assessment and prevention of breast cancer.
    Cazzaniga M; Decensi A; Bonanni B; Luini A; Gentilini O
    Curr Cancer Drug Targets; 2009 Jun; 9(4):482-99. PubMed ID: 19519317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Biomarkers of Oxidative Stress in Breast Cancer Risk and Prognosis: A Systematic Review of the Epidemiologic Literature.
    Lee JD; Cai Q; Shu XO; Nechuta SJ
    J Womens Health (Larchmt); 2017 May; 26(5):467-482. PubMed ID: 28151039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence.
    M Braden A; V Stankowski R; M Engel J; A Onitilo A
    Curr Pharm Des; 2014; 20(30):4879-98. PubMed ID: 24283956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
    Toss A; Venturelli M; Peterle C; Piacentini F; Cascinu S; Cortesi L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of the prognostic molecular biomarkers in breast cancer: A systematic review.
    Kutomi G; Mizuguchi T; Satomi F; Maeda H; Shima H; Kimura Y; Hirata K
    Oncol Lett; 2017 Mar; 13(3):1491-1498. PubMed ID: 28454281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.
    Wu HJ; Chu PY
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying cancer biomarkers by network-constrained support vector machines.
    Chen L; Xuan J; Riggins RB; Clarke R; Wang Y
    BMC Syst Biol; 2011 Oct; 5():161. PubMed ID: 21992556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.
    Ewaisha R; Gawryletz CD; Anderson KS
    Expert Rev Proteomics; 2016; 13(2):201-11. PubMed ID: 26653344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New cancer biomarkers deriving from NCI early detection research.
    Verma M; Srivastava S
    Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses.
    Yao F; Yan C; Zhang Y; Shen L; Zhou D; Ni J
    J Proteomics; 2021 Jan; 230():103991. PubMed ID: 32971305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials.
    Dhingra K; Vogel V; Sneige N; Sahin A; Aldaz CM; Hortobagyi GN; Hittelman W
    J Cell Biochem Suppl; 1993; 17G():37-43. PubMed ID: 8007707
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.